UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Description of the immune microenvironment of chondrosarcoma and contribution to progression

Oncoimmunology, 2017-02, Vol.6 (2), p.e1265716-e1265716

2017

Volltextzugriff (PDF)

KIT Mutations Induce Intracellular Retention and Activation of an Immature Form of the KIT Protein in Gastrointestinal Stromal Tumors

Clinical cancer research, 2008-04, Vol.14 (8), p.2285-2294

2008

Volltextzugriff (PDF)

Inhibition of chondrosarcoma growth by mTOR inhibitor in an in vivo syngeneic rat model

PloS one, 2012-06, Vol.7 (6), p.e32458-e32458

2012

Volltextzugriff (PDF)

The immune microenvironment of HPV-negative oral squamous cell carcinoma from never-smokers and never-drinkers patients suggests higher clinical benefit of IDO1 and PD1/PD-L1 blockade

Annals of oncology, 2017-08, Vol.28 (8), p.1934-1941

2017

Volltextzugriff (PDF)

Canarypox virus expressing wild type p53 for gene therapy in murine tumors mutated in p53

Cancer gene therapy, 2001-02, Vol.8 (2), p.87-98

2001

Volltextzugriff (PDF)

Gestion des non-conformités en structure ACP

Annales de pathologie, 2008-11, Vol.28 (1), p.S61-S62

2008

Volltextzugriff (PDF)

Cost-effectiveness analysis of strategies for HER2 testing of breast cancer patients in France

International journal of technology assessment in health care, 2006-07, Vol.22 (3), p.396-401

2006

Volltextzugriff (PDF)

Abstract C260: Dual targeting of the PI3K/Akt/mTOR pathway significantly delays chondrosarcoma progression and relapse

Molecular cancer therapeutics, 2013-11, Vol.12 (11_Supplement), p.C260-C260

2013

Volltextzugriff (PDF)

Management of non-compliance with the ACP (National Association of Technologists in Pathological Anatomy and Cytology) structure

Annales de pathologie, 2008-11, Vol.28 Spec No 1 (1), p.S61-S62

2008

Volltextzugriff (PDF)

Hepatocarcinoma-specific mutant p53-249ser induces mitotic activity but has no effect on transforming growth factor β1-mediated apoptosis

Cancer research (Chicago, Ill.), 1994, Vol.54 (8), p.2064-2068

1994

Volltextzugriff (PDF)

Weill-Marchesani syndrome: natural history and genotype-phenotype correlations from 18 news cases and review of literature

Journal of medical genetics, 2024-02, Vol.61 (2), p.109-116

2024

Volltextzugriff (PDF)

Severe adult hemophagocytic lymphohistiocytosis (HLHa) correlates with HLH-related gene variants

Journal of allergy and clinical immunology, 2024-01, Vol.153 (1), p.256-264

2024

Volltextzugriff (PDF)

Discovery of (2 S )-8-[(3 R )-3-Methylmorpholin-4-yl]-1-(3-methyl-2-oxobutyl)-2-(trifluoromethyl)-3,4-dihydro-2 H -pyrimido[1,2- a ]pyrimidin-6-one: A Novel Potent and Selective Inhibitor of Vps34 for the Treatment of Solid Tumors

Journal of medicinal chemistry, 2015-01, Vol.58 (1), p.376-400

2015

Volltextzugriff (PDF)

25 mm Hg versus 35 mm Hg elastic compression stockings to prevent post-thrombotic syndrome after deep vein thrombosis (CELEST): a randomised, double-blind, non-inferiority trial

The Lancet. Haematology, 2022-12, Vol.9 (12), p.e886-e896

2022

Volltextzugriff (PDF)

Discovery of (2S)‑8-[(3R)‑3-Methylmorpholin-4-yl]-1-(3-methyl-2-oxobutyl)-2-(trifluoromethyl)-3,4-dihydro‑2H‑pyrimido[1,2‑a]pyrimidin-6-one: A Novel Potent and Selective Inhibitor of Vps34 for the Treatment of Solid Tumors

Journal of medicinal chemistry, 2015-01, Vol.58 (1), p.376-400

2015

Volltextzugriff (PDF)

Contributions of combined techniques in the personalized treatment of pectus excavatum

Plastic and reconstructive surgery (1963), 2017-01, Vol.139 (1), p.321e-322e

2017

Volltextzugriff (PDF)

Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trialsResearch in context

EClinicalMedicine, 2024-03, Vol.69, p.102472

2024

Volltextzugriff (PDF)

25 mm Hg versus 35 mm Hg elastic compression stockings to prevent post-thrombotic syndrome after deep vein thrombosis (CELEST): a randomised, double-blind, non-inferiority trial

The Lancet. Haematology, 2022-12, Vol.9 (12), p.e886-e896

2022

Volltextzugriff (PDF)

1 – 20 von 20

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(20)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Description of the immune microenvironment of chondrosarcoma and contribution to progression

KIT Mutations Induce Intracellular Retention and Activation of an Immature Form of the KIT Protein in Gastrointestinal Stromal Tumors

Inhibition of chondrosarcoma growth by mTOR inhibitor in an in vivo syngeneic rat model

The immune microenvironment of HPV-negative oral squamous cell carcinoma from never-smokers and never-drinkers patients suggests higher clinical benefit of IDO1 and PD1/PD-L1 blockade

Canarypox virus expressing wild type p53 for gene therapy in murine tumors mutated in p53

Gestion des non-conformités en structure ACP

Cost-effectiveness analysis of strategies for HER2 testing of breast cancer patients in France

Abstract C260: Dual targeting of the PI3K/Akt/mTOR pathway significantly delays chondrosarcoma progression and relapse

Management of non-compliance with the ACP (National Association of Technologists in Pathological Anatomy and Cytology) structure

Hepatocarcinoma-specific mutant p53-249ser induces mitotic activity but has no effect on transforming growth factor β1-mediated apoptosis

Weill-Marchesani syndrome: natural history and genotype-phenotype correlations from 18 news cases and review of literature

Severe adult hemophagocytic lymphohistiocytosis (HLHa) correlates with HLH-related gene variants

Sorafenib Plus Irinotecan Combination in Patients With RAS-mutated Metastatic Colorectal Cancer Refractory To Standard Combined Chemotherapies: A Multicenter, Randomized Phase 2 Trial (NEXIRI-2/PRODIGE 27)

Discovery of (2 S )-8-[(3 R )-3-Methylmorpholin-4-yl]-1-(3-methyl-2-oxobutyl)-2-(trifluoromethyl)-3,4-dihydro-2 H -pyrimido[1,2- a ]pyrimidin-6-one: A Novel Potent and Selective Inhibitor of Vps34 for the Treatment of Solid Tumors

25 mm Hg versus 35 mm Hg elastic compression stockings to prevent post-thrombotic syndrome after deep vein thrombosis (CELEST): a randomised, double-blind, non-inferiority trial

Discovery of (2S)‑8-[(3R)‑3-Methylmorpholin-4-yl]-1-(3-methyl-2-oxobutyl)-2-(trifluoromethyl)-3,4-dihydro‑2H‑pyrimido[1,2‑a]pyrimidin-6-one: A Novel Potent and Selective Inhibitor of Vps34 for the Treatment of Solid Tumors

Contributions of combined techniques in the personalized treatment of pectus excavatum

Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trialsResearch in context

25 mm Hg versus 35 mm Hg elastic compression stockings to prevent post-thrombotic syndrome after deep vein thrombosis (CELEST): a randomised, double-blind, non-inferiority trial

Severe adult haemophagocytic lymphohistiocytosis (HLHa) correlates with HLH-related gene variants

Suchergebnisse filtern